Cytokinetics Receives Positive Analyst Coverage and Price Targets
On November 7, 2023, B. Riley Securities analyst Mayank Mamtani provided coverage on Cytokinetics (NASDAQ:CYTK), initiating a Buy rating and ...
Tag: CYTK
Cytokinetics Q3 2023 Financial Report Reveals Disappointing Performance
Cytokinetics, a leading cardiovascular biopharmaceutical company, has released its financial results for the third quarter of 2023. Unfortunately, the company's ...
Cytokinetics Inc Considers Takeover Options and Awaits Phase 3 Trial Results for Potential Breakthrough Drug
As of November 1, 2023, Cytokinetics Inc, a biotechnology company specializing in cardiovascular treatments, is reportedly considering various takeover options ...
Cytokinetics Receives Positive Outlook and Price Target Upgrade
HC Wainwright & Co. has reconfirmed its positive outlook on Cytokinetics (NASDAQ:CYTK) in a recent report, with an upgraded price ...
Cytokinetics Receives Positive Analyst Reviews and Price Target Increase
As of October 20, 2023, Cytokinetics (NASDAQ:CYTK) continues to receive positive reviews from analysts. Joseph Pantginis, an analyst at HC ...
Western Midstream Partners Announces Exciting Quarterly Cash Distribution and Upcoming Results
On October 19, 2023, the esteemed Board of Directors at Western Midstream Partners enthusiastically declared a unique and exciting quarterly ...
A Turning Point The Event that Sparked Global Transformation
On October 9, 2023, a significant event took place that left a lasting impact on the world. This event, which ...
JMP Securities Analyst Reiterates Optimism for Cytokinetics with 71 Price Target
On October 9, 2023, JMP Securities analyst Jason Butler expressed his continued optimism for Cytokinetics (NASDAQ:CYTK) by reiterating his Market ...
Preliminary Details of SEQUOIAHCM Study Participants and Trial Overview
On October 6, 2023, Cytokinetics unveiled the preliminary details of the participants involved in the SEQUOIA-HCM study during the HCM ...
Institutional Investors Make Massive Block Trade in Cytokinetics Inc CYTK
On September 18, 2023, a substantial block trade took place involving the stock of Cytokinetics, Inc. (CYTK). This trade, which ...